Accolade, Inc. provides personalized health and benefits solutions with a focus on improving health outcomes and reducing costs for employers and their employees. The company generates revenue by offering a platform that integrates health advocacy, navigation services, and clinical programs, typically under subscription models or service contracts with businesses and health plans.
The ten most recent trades of Accolade in the ARKG ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
---|---|---|---|---|
Feb 07, 2025 | Sell | $2,769,518 | 18.85% | 0.23% |
Feb 06, 2025 | Sell | $2,108,745 | 12.70% | 0.17% |
Feb 05, 2025 | Sell | $686,647 | 4.02% | 0.06% |
Feb 04, 2025 | Sell | $1,372,893 | 7.36% | 0.12% |
Feb 03, 2025 | Sell | $557,239 | 2.91% | 0.05% |
Jan 31, 2025 | Sell | $2,119,584 | 9.79% | 0.17% |
Jan 30, 2025 | Sell | $2,467,072 | 10.22% | 0.21% |
Jan 29, 2025 | Sell | $704,674 | 2.84% | 0.06% |
Jan 28, 2025 | Sell | $309,889 | 1.23% | 0.03% |
Jan 23, 2025 | Sell | $243,963 | 0.97% | 0.02% |